Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-056913

Director sold 3,556 shares at $29.06 ($103,337)

From the SEC's structured data for this filing

Trades in this filing

GADICKE ANSBERT · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-16 Sale : show line 1 in the form −432 $29.06 $12,554 244,551 D
2021-09-16 Sale : show line 2 in the form −3,124 $29.06 $90,783 7,648,268 I
Open-market sales · 3,556 sh · avg $29.06 · $103,337
Loading xslF345X03/doc4.xml…